Synthetic target trial emulation and predictive modeling of amylin-pathway therapies for obesity and type 2 diabetes.
- DOI
- 10.1016/j.metop.2025.100414
- Published
- 2025 Dec
- Container
- Metabolism open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.metop.2025.100414,
title = {Synthetic target trial emulation and predictive modeling of amylin-pathway therapies for obesity and type 2 diabetes.},
author = {Al-Harbi FA and Alsaif AK and Almutairi AG and Alshehri HJ and Aleidan EA and Alabdulaaly GS and Alanazi ME and Azzam AY},
year = {2025},
journal = {Metabolism open},
doi = {10.1016/j.metop.2025.100414},
url = {https://doi.org/10.1016/j.metop.2025.100414}
}RIS
TY - JOUR TI - Synthetic target trial emulation and predictive modeling of amylin-pathway therapies for obesity and type 2 diabetes. AU - Al-Harbi FA AU - Alsaif AK AU - Almutairi AG AU - Alshehri HJ AU - Aleidan EA AU - Alabdulaaly GS AU - Alanazi ME AU - Azzam AY PY - 2025 JO - Metabolism open DO - 10.1016/j.metop.2025.100414 UR - https://doi.org/10.1016/j.metop.2025.100414 ER -
APA
FA, A., AK, A., AG, A., HJ, A., EA, A., GS, A., ME, A., & AY, A. (2025). Synthetic target trial emulation and predictive modeling of amylin-pathway therapies for obesity and type 2 diabetes.. Metabolism open. https://doi.org/10.1016/j.metop.2025.100414
Source records
- pubmed · retrieved 2026-09-25T13:30:00.771Z
- europe-pmc · retrieved 2026-09-25T13:30:00.780Z
- doaj · retrieved 2026-09-25T13:30:00.799Z